Literature DB >> 3201757

The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer.

R Tur-Kaspa1, Y Shaul, D D Moore, R D Burk, S Okret, L Poellinger, D A Shafritz.   

Abstract

The hepatitis B virus (HBV) genome contains a specific DNA binding site for the glucocorticoid receptor. Using DNase I footprinting, this binding site was localized at HBV map positions 341-370 clockwise from the EcoRI site. The DNA sequence protected in the footprint contains two tandem copies of the GRE core hexanucleotide 5'-TGTTCCT-3'. Deletion analysis and reconstruction experiments in plasmid expression vectors demonstrated that this glucocorticoid receptor binding sequence serves as a signal for augmenting glucocorticoid-dependent activity of the HBV enhancer, which is located approximately 730 nucleotides downstream in the HBV genome. Even though it does not serve as an independent enhancer element, the HBV glucocorticoid receptor domain can therefore be categorized as a functional GRE.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3201757

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

Review 1.  Treatment of follicular non-Hodgkin's lymphoma.

Authors:  David G Maloney
Journal:  Curr Hematol Rep       Date:  2005-01

2.  Successful treatment with corticosteroid and lamivudine for autoimmune hepatitis in a patient with asymptomatic HBV infection.

Authors:  Reiichiro Kuwahara; Hiroki Saitsu; Mitsuhiko Abe; Akio Takata; Kazuo Tanaka; Teruko Hino; Tatsuya Ide; Ryoko Kuromatsu; Ken Tanikawa; Masayoshi Kage; Ryukichi Kumashiro; Michio Sata
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

3.  A new enhancer element, ENII, identified in the X gene of hepatitis B virus.

Authors:  Y Wang; P Chen; X Wu; A L Sun; H Wang; Y A Zhu; Z P Li
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

4.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

Review 5.  Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.

Authors:  Pilar López-Serrano; Elsa de la Fuente Briongos; Elisa Carrera Alonso; Jose Lázaro Pérez-Calle; Conrado Fernández Rodríguez
Journal:  World J Hepatol       Date:  2015-03-27

6.  Functional organization of the hepatitis B virus enhancer.

Authors:  R Dikstein; O Faktor; R Ben-Levy; Y Shaul
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

7.  Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2011-06-14       Impact factor: 6.047

8.  Critical roles of nuclear receptor response elements in replication of hepatitis B virus.

Authors:  X Yu; J E Mertz
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

9.  Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily.

Authors:  X Yu; J E Mertz
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

10.  Transcription of the S gene in transgenic mice is associated with hypomethylation at specific sites and with DNase I sensitivity.

Authors:  C Pourcel; P Tiollais; H Farza
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.